Insulin resistance is a central feature of the metabolic syndromes and represents a serious and common complication of obesity during childhood and adolescence. An early diagnosis and appropriated prevention and treatment are important in order to reduce associated risk of metabolic and cardiovascular complications, thereby, improve health of our children and strengthen our societies in the future.
Phouvang Sengmeuang received financial support for studying towords a PhD program in Medical Physiology from the Khon Kaen University Scholarship for Human Resource Development of Neighboring Countries and the Faculty of Medicine, Khon Kaen University.
1 Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999; 22: 345-54.
2 Caprio S. Insulin resistance in childhood obesity. J Pediatr Endocrinol Metab 2002; 15 Suppl 1: 487-92.
3 Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 1992; 327: 1350-5.
4 Berenson GS, Srinivasan SR, Bao W, Newman WP, 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998; 338: 1650-6.
5 Weiss R, Kaufman FR. Metabolic complications of childhood obesity: identifying and mitigating the risk. Diabetes Care 2008; 31 Suppl 2: S310-6.
6 Guo SS, Wu W, Chumlea WC, Roche AF. Predicting overweight and obesity in adulthood from body mass index values in childhood and adolescence. Am J Clin Nutr 2002; 76: 653-8.
7 Jirapinyo P, Densupsoontorn N, Chinrungrueng D, Wongarn R, Thamonsiri N. Relative risks of becoming overweight and obese in children after 6 years in secondary school. J med Assoc Thai 2005; 88: 651-4.
8 Nguyen T, Kamsrichan W, Chompikul J. Obesity and related factors among students grade 7-12 in Phutthamonthon Districts, Nakhon Pathom, Thailand. J of Public Health and Development 2008; 6: 91-101.
9 Krissanapant W, Sengmeuang P, Pasurivong O, Kukongviriyapan U. Does Cardiac Autonomic Modulation Exist in Obese Adolescent? Srinagarind Med J 2008; 23: 234-239.
10 Rosenberg B, Moran A, Sinaiko AR. Insulin resistance (metabolic) syndrome in children. Panminerva Med 2005; 47: 229-44.
11 Matthaei S, Stumvoll M, Kellerer M, Haring HU. Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev 2000; 21: 585-618.
12 Bajaj M, Defronzo RA. Metabolic and molecular basis of insulin resistance. J Nucl Cardiol 2003; 10: 311-23.
13 Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, . Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000; 105: 311-20.
14 Kim YB, Nikoulina SE, Ciaraldi TP, Henry RR, Kahn BB. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest 1999; 104: 733-41.
15 Caprio S, Bronson M, Sherwin RS, Rife F, Tamborlane WV. Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children. Diabetologia 1996; 39: 1489-97.
16 Lee JM, Okumura MJ, Davis MM, Herman WH, Gurney JG. Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study. Diabetes Care 2006; 29: 2427-32.
17 Matsuzawa Y. White adipose tissue and cardiovascular disease. Best Pract Res Clin Endocrinol Metab 2005; 19: 637-47.
18 Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, . Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999; 48: 1270-4.
19 Gil-Campos M, Canete RR, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 2004; 23: 963-74.
20 Taksali SE, Caprio S, Dziura J, Dufour S, Cali AM, Goodman TR, . High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype. Diabetes 2008; 57: 367-71.
21 Caprio S, Hyman LD, Limb C, McCarthy S, Lange R, Sherwin RS, . Central adiposity and its metabolic correlates in obese adolescent girls. Am J Physiol 1995; 269: E118-26.
22 Jacob S, Machann J, Rett K, Brechtel K, Volk A, Renn W, . Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 1999; 48: 1113-9.
23 Thamer C, Machann J, Bachmann O, Haap M, Dahl D, Wietek B, . Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. J Clin Endocrinol Metab 2003; 88: 1785-91.
24 Weiss R, Taksali SE, Dufour S, Yeckel CW, Papademetris X, Cline G, . The "obese insulin-sensitive" adolescent: importance of adiponectin and lipid partitioning. J Clin Endocrinol Metab 2005; 90: 3731-7.
25 Weiss R, Dufour S, Taksali SE, Tamborlane WV, Petersen KF, Bonadonna RC, . Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 2003; 362: 951-7.
26 Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 2003; 285: E906-16.
27 Yudkin JS, Eringa E, Stehouwer CD. "Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 2005; 365: 1817-20.
28 Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-28.
29 Marcovecchio ML, Patricelli L, Zito M, Capanna R, Ciampani M, Chiarelli F, . Ambulatory blood pressure monitoring in obese children: role of insulin resistance. J Hypertens 2006; 24: 2431-6.
30 Cruz ML, Huang TT, Johnson MS, Gower BA, Goran MI. Insulin sensitivity and blood pressure in black and white children. Hypertension 2002; 40: 18-22.
31 Howard BV, Howard WJ. Dyslipidemia in non-insulin-dependent diabetes mellitus. Endocr Rev 1994; 15: 263-74.
32 Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, . Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002; 346: 802-10.
33 D'Adamo E, Impicciatore M, Capanna R, Loredana Marcovecchio M, Masuccio FG, Chiarelli F, . Liver steatosis in obese prepubertal children: a possible role of insulin resistance. Obesity (Silver Spring) 2008; 16: 677-83.
34 Dandona P, Aljada A, Mohanty P. The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 2002; 45: 924-30.
35 Bacha F, Saad R, Gungor N, Arslanian SA. Are obesity-related metabolic risk factors modulated by the degree of insulin resistance in adolescents? Diabetes Care 2006; 29: 1599-604.
36 Alberti G, Zimmet P, Shaw J, Bloomgarden Z, Kaufman F, Silink M. Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop. Diabetes Care 2004; 27: 1798-811.
37 Sinaiko AR, Steinberger J, Moran A, Hong CP, Prineas RJ, Jacobs DR, Jr. Influence of insulin resistance and body mass index at age 13 on systolic blood pressure, triglycerides, and high-density lipoprotein cholesterol at age 19. Hypertension 2006; 48: 730-6.
38 Lurbe E, Torro I, Aguilar F, Alvarez J, Alcon J, Pascual JM, . Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents. Hypertension 2008; 51: 635-41.
39 DeFronzo RA. The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia 1981; 21: 165-71.
40 Landsberg L. Insulin resistance and hypertension. Clin Exp Hypertens 1999; 21: 885-94.
41 Maclaren NK, Gujral S, Ten S, Motagheti R. Childhood obesity and insulin resistance. Cell Biochem Biophys 2007; 48: 73-8.
42 Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004; 114: 147-52.
43 Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X, . Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 2006; 91: 4287-94.
44 Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, . Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362-74.
45 Rosenfield RL. Clinical review: Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92: 787-96.
46 Palmert MR, Gordon CM, Kartashov AI, Legro RS, Emans SJ, Dunaif A. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87: 1017-23.
47 Al-Shawwa BA, Al-Huniti NH, DeMattia L, Gershan W. Asthma and insulin resistance in morbidly obese children and adolescents. J Asthma 2007; 44: 469-73.
48 Barlow SE. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 2007; 120 Suppl 4: S164-92.
49 Whitaker RC, Pepe MS, Wright JA, Seidel KD, Dietz WH. Early adiposity rebound and the risk of adult obesity. Pediatrics 1998; 101: E5.
50 Dietz WH. Overweight in childhood and adolescence. N Engl J Med 2004; 350: 855-7.
51 Davis MM, Gance-Cleveland B, Hassink S, Johnson R, Paradis G, Resnicow K. Recommendations for prevention of childhood obesity. Pediatrics 2007; 120 Suppl 4: S229-53.
52 Flodmark CE, Marcus C, Britton M. Interventions to prevent obesity in children and adolescents: a systematic literature review. Int J Obes (Lond) 2006; 30: 579-89.
53 Reinehr T, Kiess W, Kapellen T, Andler W. Insulin sensitivity among obese children and adolescents, according to degree of weight loss. Pediatrics 2004; 114: 1569-73.
54 Bell LM, Watts K, Siafarikas A, Thompson A, Ratnam N, Bulsara M, . Exercise alone reduces insulin resistance in obese children independently of changes in body composition. J Clin Endocrinol Metab 2007; 92: 4230-5.
55 Freemark M, Bursey D. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics 2001; 107: E55.
56 Kay JP, Alemzadeh R, Langley G, D'Angelo L, Smith P, Holshouser S. Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metabolism 2001; 50: 1457-61.
57 Berkowitz RI, Wadden TA, Tershakovec AM, Cronquist JL. Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial. Jama 2003; 289: 1805-12.
58 Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. Jama 2005; 293: 2873-83.
59 Yki-Jarvinen H. Thiazolidinediones. N Engl J Med 2004; 351: 1106-18.